Luxdegalutamide is an orally active PROTAC that targets the androgen receptor (AR) for degradation, including resistant mutants such as T878, H875, and L702. Its structural design facilitates the study of mechanisms related to castration-resistant prostate cancer. Reagent-grade; for laboratory research purposes only.
Products > PROTAC, Molecular glue > Degraders
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。